ESC Professional Premium Access

Emerging role of genetic testing for ventricular arrhythmia management

Event: ESC Congress 2022
Topic: Genetic Aspects of Arrhythmias
Session type: Abstract Sessions
Date: 27 August 2022
Time: 11:30 - 12:20

Congress Session

5 presentations in this session

SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome

Speaker: Professor V. Probst (Nantes, FR)
Thumbnail

Natural History of Patients with Typical and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia

Speaker: Doctor A. Trancuccio (Pavia, IT)
Thumbnail

Calmodulinopathy is a common cause of critical cardiac phenotypes in fetus and infancy

Speaker: Doctor M. Fukuyama (Otsu, JP)
Thumbnail

Longitudinal validation of the phospholamban (PLN) p.Arg14del risk model

Speaker: Miss M. Van Der Heide (Amsterdam, NL)
Thumbnail

Efficacy and safety of the ICD in patients with catecholaminergic polymorphic ventricular tachycardia

Speaker: Assistant Professor A. Mazzanti (Pavia, IT)
Thumbnail

5 speakers from this session

Professor Vincent Probst

University Hospital of Nantes, Nantes (France)
7 presentations
0 follower

Doctor Alessandro Trancuccio

University of Pavia, Pavia (Italy)
0 follower

Doctor Megumi Fukuyama

Shiga University of Medical Science, Otsu (Japan)
0 follower

Miss Myrthe Van Der Heide

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

Assistant Professor Andrea Mazzanti

MEDICAL CENTRE OF PAVIA Scientific Institute for Research and Healthcare, Pavia (Italy)
5 presentations
0 follower

This platform is supported by

logo Novo Nordisk